{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T15:23:30Z","timestamp":1726500210875},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.neuroimage.2005.08.013","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T07:21:28Z","timestamp":1127373688000},"page":"545-556","source":"Crossref","is-referenced-by-count":39,"title":["Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: A randomized, placebo-controlled, double-blind fMRI study"],"prefix":"10.1016","volume":"29","author":[{"given":"Veena","family":"Kumari","sequence":"first","affiliation":[]},{"given":"Ingrid","family":"Aasen","sequence":"additional","affiliation":[]},{"given":"Dominic","family":"ffytche","sequence":"additional","affiliation":[]},{"given":"Steven C.R.","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Tonmoy","family":"Sharma","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.schbul.a033363","article-title":"Neurocognitive and social functioning in schizophrenia","volume":"25","author":"Addington","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"year":"1986","series-title":"Working Memory","author":"Baddeley","key":"10.1016\/j.neuroimage.2005.08.013_bib3"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/nimg.2001.0788","article-title":"A parametric fMRI study of overt and covert shifts of visuospatial attention","volume":"4","author":"Beauchamp","year":"2001","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0896-6273(04)00145-X","article-title":"Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory","volume":"41","author":"Bentley","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1176\/appi.ajp.160.3.483","article-title":"Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder","volume":"160","author":"Bertolino","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib8","first-page":"CD001191","article-title":"Rivastigmine for Alzheimer's disease","volume":"4","author":"Birks","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2001-18037","article-title":"Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study","volume":"34","author":"Braus","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(02)00003-2","article-title":"Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia","volume":"12","author":"Braus","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0920-9964(01)00387-5","article-title":"An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia","volume":"59","author":"Buchanan","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cercor\/9.1.20","article-title":"Physiological characteristics of capacity constraints in working memory as revealed in functional MRI","volume":"9","author":"Callicott","year":"1999","journal-title":"Cereb. Cortex"},{"issue":"10","key":"10.1016\/j.neuroimage.2005.08.013_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.v62n1004","article-title":"Treatment of tardive dyskinesia with donepezil: a pilot study","volume":"62","author":"Caroff","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/syn.890070209","article-title":"The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory","volume":"7","author":"Decker","year":"1991","journal-title":"Synapse"},{"issue":"Suppl. 9","key":"10.1016\/j.neuroimage.2005.08.013_bib17","first-page":"11","article-title":"Current treatments for Alzheimer's disease: cholinesterase inhibitors","volume":"64","author":"Doody","year":"2003","journal-title":"J. Clin. Psychiatry"},{"year":"1987","series-title":"California Verbal Learning Test Manual","author":"Delis","key":"10.1016\/j.neuroimage.2005.08.013_bib18"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib19","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/sj.npp.1300286","article-title":"Effects of procyclidine on eye movements in schizophrenia","volume":"28","author":"Ettinger","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1016\/j.neuroimage.2005.08.013_bib20","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuroimage.2005.08.013_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0006-3223(02)01476-2","article-title":"The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients","volume":"53","author":"Evans","year":"2003","journal-title":"Biol. Psychiatry"},{"year":"1995","series-title":"Structured Clinical Interview for DSM-IV Axis I disorders","author":"First","key":"10.1016\/j.neuroimage.2005.08.013_bib22"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-004-1794-x","article-title":"Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists","volume":"174","author":"Friedman","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(98)00287-X","article-title":"Pharmacologic strategies for augmenting cognitive performance in schizophrenia","volume":"45","author":"Friedman","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-3223(01)01342-7","article-title":"A double-blind placebo-controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia","volume":"51","author":"Friedman","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mrm.1910350312","article-title":"Movement related effects in fMRI time series","volume":"35","author":"Friston","year":"1996","journal-title":"Mag. Res. Med."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nimg.1999.0439","article-title":"How many subjects constitute a study?","volume":"10","author":"Friston","year":"1999","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib28","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1073\/pnas.94.12.6512","article-title":"Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory","volume":"94","author":"Furey","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib29","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1126\/science.290.5500.2315","article-title":"Cholinergic enhancement and increased selectivity of perceptual processing during working memory","volume":"290","author":"Furey","year":"2000","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.neuroimage.2005.08.013_bib30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuroimage.2005.08.013_bib31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cercor\/bhg082","article-title":"Interindividual differences in functional interactions among prefrontal, parietal and parahippocampal regions during working memory","volume":"13","author":"Glabus","year":"2003","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.neuroimage.2005.08.013_bib32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.neuroimage.2004.08.006","article-title":"Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study","volume":"23","author":"Goekoop","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib34","first-page":"799","article-title":"Does risperidone improve verbal working memory in treatment-resistant schizophrenia?","volume":"54","author":"Green","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib35","unstructured":"Guy, W. (ed.), 1976. ECCDEU Assessment manual for psychopharmacology (revised). National Institutes of mental Health, Rockville, MD, DHEW publication no. (ADM) 76-338."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hup.676","article-title":"A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis","volume":"20","author":"Harry","year":"2005","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v65n0312","article-title":"Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness","volume":"65","author":"Harvey","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"23","key":"10.1016\/j.neuroimage.2005.08.013_bib38","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.96.23.13432","article-title":"Differences in frontal cortical activation by a working memory task following substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia","volume":"96","author":"Honey","year":"1999","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/026988110201600313","article-title":"Donepezil for memory dysfunction in schizophrenia","volume":"16","author":"Howard","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric disorders","volume":"143","author":"Hughes","year":"1986","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.neuroimage.2005.08.013_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0920-9964(01)00393-0","article-title":"Longitudinal study of symptoms and cognitive function in chronic schizophrenia","volume":"59","author":"Hughes","year":"2003","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self-medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002130000656","article-title":"Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers","volume":"154","author":"Kumari","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0269881103017001710","article-title":"Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double blind, placebo-controlled study","volume":"17","author":"Kumari","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib47","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1053-8119(03)00110-1","article-title":"Cognitive effects of nicotine in humans: a functional MRI Investigation","volume":"19","author":"Kumari","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib49","first-page":"82","article-title":"Effects of clozapine on cognitive function in schizophrenia","volume":"55","author":"Lee","year":"1994","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00002826-200311000-00011","article-title":"Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia","volume":"26","author":"Lenzi","year":"2003","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.0001-690X.2001.acp1c008d.x","article-title":"Donepezil in schizophrenia\u2014is it helpful? An experimental design case study","volume":"104","author":"MacEwan","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","article-title":"Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease","volume":"49","author":"Maelicke","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib53","first-page":"612","article-title":"Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers","volume":"251","author":"Mandel","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5\u20136","key":"10.1016\/j.neuroimage.2005.08.013_bib54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1097-0193(1998)6:5\/6<383::AID-HBM10>3.0.CO;2-Z","article-title":"ERP and fMRI measures of visual spatial selective attention","volume":"6","author":"Mangun","year":"1998","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.neuroimage.2005.08.013_bib55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/7274","article-title":"Involvement of striate and extrastriate visual cortical areas in spatial attention","volume":"2","author":"Martinez","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.185.3.205","article-title":"Changes in distributed neural circuitry function in patients with first-episode schizophrenia","volume":"185","author":"Mendrek","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2001.0462","article-title":"Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain","volume":"9","author":"Mesulam","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(03)00107-0","article-title":"Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia","volume":"124","author":"Molina","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1076\/neur.9.3.274.15563","article-title":"Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study","volume":"9","author":"Nahas","year":"2003","journal-title":"Neurocase"},{"year":"1991","series-title":"National Adult Reading Test: Part II. Test Manual","author":"Nelson","key":"10.1016\/j.neuroimage.2005.08.013_bib60"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib61","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1073\/pnas.87.24.9868","article-title":"Brain magnetic resonance imaging with contrast dependent blood oxygenation","volume":"87","author":"Ogawa","year":"1990","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.neuroimage.2005.08.013_bib62","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/appi.ajp.158.7.1105","article-title":"Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia","volume":"158","author":"Perlstein","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib86","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0149-2918(98)80127-6","article-title":"Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"20","author":"Polinsky","year":"1998","journal-title":"Clin. Therapeutics"},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1461145701002528","article-title":"Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease","volume":"4","author":"Potkin","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.schbul.a033330","article-title":"Postmortem studies in schizophrenia","volume":"24","author":"Powchik","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/neucas\/7.2.105","article-title":"A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates","volume":"7","author":"Risch","year":"2001","journal-title":"Neurocase"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial","volume":"318","author":"Rosler","year":"1999","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0447.1997.tb00371.x","article-title":"Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study","volume":"95","author":"Rossi","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/gps.1312","article-title":"Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy","volume":"20","author":"Rozzini","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/oxfordjournals.schbul.a033337","article-title":"A review of longitudinal studies of cognitive functions in schizophrenia patients","volume":"24","author":"Rund","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib70","first-page":"1","article-title":"Agonist responses of neuronal nicotinic receptors are potentiated by a novel class of allosterically acting ligands","volume":"46","author":"Schrattenholz","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"Pt. 12","key":"10.1016\/j.neuroimage.2005.08.013_bib72","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","article-title":"Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain","volume":"121","author":"Selden","year":"1998","journal-title":"Brain"},{"year":"2000","series-title":"Cognition in Schizophrenia: Impairments, Importance, and Treatment Strategies","author":"Sharma","key":"10.1016\/j.neuroimage.2005.08.013_bib71"},{"issue":"Supp. 212","key":"10.1016\/j.neuroimage.2005.08.013_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for the extrapyramidal side effects","volume":"45","author":"Simpson","year":"1970","journal-title":"Acta Psychiat. Scand."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/cogp.1997.0658","article-title":"Working memory: a view from neuroimaging","volume":"33","author":"Smith","year":"1997","journal-title":"Cogn. Psychol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0920-9964(90)90045-9","article-title":"Effects of anticholinergic medication on memory in schizophrenia","volume":"3","author":"Strauss","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00004714-200204000-00021","article-title":"Donepezil management of schizophrenia with associated dementia","volume":"22","author":"Stryjer","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuroimage.2005.08.013_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002826-200301000-00004","article-title":"Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia","volume":"26","author":"Stryjer","year":"2003","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib78","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S1461145703004024","article-title":"A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia","volume":"7","author":"Tugal","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuroimage.2005.08.013_bib80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00001756-200201210-00020","article-title":"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease","volume":"13","author":"Vennerica","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroimage.2005.08.013_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(97)00010-8","article-title":"The functional significance of symptomatology and cognitive function in schizophrenia","volume":"25","author":"Velligan","year":"1997","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.neuroimage.2005.08.013_bib82","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0149-2918(03)80160-1","article-title":"A review of rivastigmine: a reversible cholinesterase inhibitor","volume":"25","author":"Williams","year":"2003","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.neuroimage.2005.08.013_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"1997","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neuroimage.2005.08.013_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00004714-200204000-00020","article-title":"Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia","volume":"22","author":"Zachariah","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811905005872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811905005872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T12:29:10Z","timestamp":1553516950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811905005872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1053811905005872"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2005.08.013","relation":{},"ISSN":["1053-8119"],"issn-type":[{"type":"print","value":"1053-8119"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}